NEW JERSEY ALLIANCE FOR

CLINICAL AND TRANSLATIONAL SCIENCE

NEWS, EVENTS, and DEADLINES

October 20, 2022

Upcoming NJ ACTS, Rutgers & Princeton Events

NJ ACTS Team Science Core

Alan Alda Center for Communicating Science

Virtual Workshop Series

Creating Connections

Tuesday, October 25

3 pm - 5 pm

The Alda Center's foundational programs offer scientists and researchers a variety of ways to begin to explore ways to engage audiences effectively, build trust, and share the wonder and joy of their work. (Alan Alda Center at https://aldacenter.org/)

Space is Limited - Register to receive the Zoom Link

Questions? Contact njacts@rbhs.rutgers.edu

NJ ACTS Special Populations Core

2022 Seminar Series

What Makes Us Unequal?

Understanding Disagreement Regarding

Genes and Social Inequality

Sam Trejo, PhD

Princeton University

Dr. Trejo is an Assistant Professor of Sociology at Princeton University and is interested in how social and biological factors jointly shape human development across the life-course.

Discussions of social inequality are often polarizing – such conversations only become more controversial when the role of genetic factors is added into the mix. Even people who seem to share a commitment to reducing inequality can fiercely disagree about the relevance of genes and the risks and benefits of social and behavioral genomics research. Here, Dr. Trejo argues that often these disagreements stem from differing answers to the following question: to what extent do genetic differences between individuals produce social inequality?

October 25, 2022

1 pm - 2 pm

Join on Zoom

View Flyer

Life Science Funding and Incentives in New Jersey

Learn about New Jersey’s funding and incentive programs and hear from New Jersey’s life sciences industry leaders who have benefited from these important incentive funding programs.

October 20, 2022

5 pm - 6:30 pm

The Princeton Pulse Podcast

A new podcast exploring the power and possibilities of evidence-informed health policy hosted by Heather Howard, professor of the practice and former New Jersey Commissioner of Health and Senior Services, the show brings together scholars, policymakers, and other leaders to examine today’s most pressing health policy issues – domestically and globally.

In the inaugural episode, Howard is joined by New Jersey First Lady Tammy Synder Murphy and Elizabeth Armstrong, associate professor of sociology and public affairs, to confront the racial divide in maternal and infant health.

Available on the CHW website, Apple Podcasts, Spotify, and other podcast platforms.

Federal Grant Will Help Train Future Public Health Professionals

The Rutgers School of Public Health will be strengthening the public health workforce throughout New Jersey by providing 50 percent tuition scholarships to 84 students thanks to a $1.5 million award from the Health Resources and Services Administration (HRSA). The scholarship money will be evenly split between current employees of state and local health programs without formal training in public health and underrepresented minorities in New Jersey who wish to enter the public health profession.

Read the Full Article

NJ ACTS in the News

Alexander Ploss

More possible entry points for COVID spike protein identified by Princeton scientists

One of the essential factors the COVID-19 virus needs to enter a host is a receptor on a human cell — a place where the universally recognized spike protein can latch onto the cell surface, pierce it, disgorge its infectious contents, and replicate. Without a receptor, there is no replication. Without replication, there is no infection.

NJ ACTS congratulates Alexander Ploss, a leading virologist and professor of molecular biology as well as an NJ ACTS Pilot Award recipient, and his colleague David MacMillan, the James S. McDonnell Distinguished University Professor and a Nobel laureate in chemistry on this important research. Read the Full Article

NJ ACTS Congratulates Celeste Nelson

Princeton professor Celeste Nelson is among 103 researchers nationwide to receive 2022 High-Risk, High-Reward research awards from the National Institutes of Health (NIH), created to support unconventional approaches to major challenges in biomedical and behavioral research.

Read the Full Article

Dr. Nelson, with Shridar Ganesan, MD, PhD of Rutgers, was awarded an NJ ACTS Pilot Grant in 2021 to study "The effects of cell and tissue-level heterogeneity on triple-negative breast cancer progression".

Celeste Nelson

Regional Postdoctoral Competition

Blavatnik Awards for Young Scientists

The Blatvatnik Award s are for the most promising postdoctoral scientists and engineers working in disciplines within the life sciences, physical sciences & engineering, and chemistry. Winners will be awarded $30,000 each in unrestricted funds.

Please visit the Blavatnik website for more detailed guidelines. To nominate a Rutgers candidate, please upload to InfoReady, a research summary (1,000 words maximum), list of publications after graduate training, curriculum vitae, and a letter of nomination no later than October 31, 2022.

NJ ACTS Services

NJ ACTS Regulatory Knowledge and Support Topics

Wondering what's The differences between the Scientific Review Board (SRB) and Institutional Review Board (IRB) The Regulatory Core has the answers.

Check out the NJ ACTS Toolbox for More Topics and Tips

NJ ACTS Deadline - KL2 Scholar

KL2 Career Development Scholar

Full applications are due November 1, 2022 at 5 p.m.

For more information contact kl2njacts@rbhs.rutgers.edu

RECOVER COVID Website Updates

COVID Study Opportunity

RECOVER studies are currently enrolling. Whether or not you have had COVID, you may be able to participate in RECOVER research. For more information about what to expect when participating in a study, visit recovercovid.org.

RECOVER list of Post-Infection Illness Experts

is now available on recovercovid.org. This document lists the investigators and clinicians contributing to RECOVER who have research expertise and clinical experience with post-acute infection syndromes, such as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), dysautonomia, and other illnesses.

CTSA News and Events

National Center for Advancing Translational Science (NCATS)

ENACT: A New CTSA Consortium-Wide

EHR Research Platform

The NCATS-funded Evolve to Next-Gen ACT (ENACT) is a collaborative research platform that will enable investigators at CTSA hubs to conduct EHR research on any disease or condition from their desktop. Using de-identified data from EHRs for >142 million patients at 57 hubs, ENACT will also allow data scientists to develop and test EHR-based research tools. Read More

NJ ACTS Publications

Development of a text message-based intervention for follow-up colonoscopy among predominately underserved Black and Hispanic/Latinx women. Sansoni M, Tagi EK, Lapitan E, Wen KY, Xu J, Belfiglio A, Hudson SV, Kohler RE, Hernandez E, Miller SM. Cancer Causes Control. 2022 Mar 25. PMID: 35334016. DOI: 10.1007/s10552-022-01573-y. Online ahead of print.

Demonstrating an approach for evaluating synthetic geospatial and temporal epidemiologic data utility: Results from analyzing > 1.8million SARS-CoV-2 tests in the United States National COVID Cohort Collaborative (N3C). Thomas JA, Foraker RE, Zamstein N, Payne PRO, Wilcox AB; N3C Consortium. J Am Med Inform Assoc. 2022 Mar 31;ocac045. Online ahead of print. PMID: 3537487. PMCID: PMC8992357. DOI: 10.1093/jamia/ocac045.

Click Here for More NJ ACTS Publications

In Case You Missed IT

Translational Science 2023 - is looking for new ways to innovate translational science for research. Submissions are now open for poster and scientific session proposals!

New Jersey Health Foundation $2 Million Grant Program for Research - (up to $35,000 each) or Community Health and Social Service (up to $25,000 each). Sponsor deadline: November 7, 2022

Propelus I-Corps Program - Rolling applications for a 4-week program for researchers to explore the commercial potential for their innovations through Customer Discovery. Accepted teams are awarded a $3,000 NSF grant which makes them eligible to get follow-on NSF funding. https://icorpsnortheasthub.org/

Build a Successful Collaboration with NJ ACTS Team Science - The Team Science Core offers general and project-specific consultations on building and maintaining successful research teams and collaborations. To set up a consultation, please fill out the intake form. Read more about the Team Science Core.

Clinical Trials Office - Join the Clinical Research Investigator Registry. The purpose of this registry is to match investigators with potential clinical trial opportunities that we are informed of through our industry and academic partnerships. Fill out a Brief Form to Register and Learn More about the Clinical Trials Office

View NJ ACTS Services

Click Here for NJ ACTS Newsletter Archive

NJ ACTS is a partnership between Rutgers, NJIT and Princeton. NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health.

Components

Clinical Trials Office

Visit NJ ACTS

View NJ ACTS Calendar

CTSA Hub Funding Opportunities

Become a members of NJ ACTS.

How to cite the CTSA Grant

Connect with us

This newsletter is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number, UL1TR003017 to Rutgers University. The content is solely the responsibility of the authors and does not represent the official views of the NIH.

New Jersey Alliance for Clinical and Translational Science

89 French St., Suite 4211

New Brunswick, NJ

Send story ideas to NJACTS@rbhs.rutgers.edu

UL1TR003017, KL2TR003018 and TL1TR003019